58
Participants
Start Date
January 20, 2020
Primary Completion Date
June 1, 2023
Study Completion Date
June 1, 2023
AMG 199
AMG 199 is a BiTE® molecule designed to direct T cells towards MUC17-expressing cells.
Landeskrankenhaus Salzburg, Salzburg
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Universitaetsklinikum Hamburg Eppendorf Onkologisches Zentrum, Hamburg
Wake Forest University Health Sciences, Winston-Salem
Hospital Clinico Universitario de Valencia, Valencia
Klinikum der Universitaet Muenchen Campus Grosshadern, München
Klinikum rechts der Isar, München
City of Hope National Medical Center, Duarte
University of California at Irvine Medical Center, Orange
Institut Gustave Roussy, Villejuif
Universitaetsklinikum Leipzig, Leipzig
Aichi Cancer Center, Nagoya
National Cancer Center Hospital East, Kashiwa-shi
National Cancer Center Hospital, Chuo-ku
Amsterdam UMC - location VUmc, Amsterdam
Leids Universitair Medisch Centrum, Leiden
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Hospital Universitari Vall d Hebron, Barcelona
Lead Sponsor
Amgen
INDUSTRY